NovaDel Partners with BioAlliance Pharma SA to Bring Ondansetron Oral Spray to Market

NovaDel has entered into a collaboration agreement with BioAlliance Pharma SA for the development and commercialization of NovaDel’s ondansetron oral spray (OS) for Europe. Ondansetron is a 5-HT3 antagonist to prevent nausea and vomiting after chemotherapy, radiation and surgery. Upon successful...

Cepheid Expands Reach with Novation Partnership

Cepheid has signed a group purchasing contract with Novation, making its GeneXpert System and Xpert MRSA tests widely available in the U.S. at lower, pre-negotiated prices. Novation represents 49% of admissions, 52% of total surgeries and 44% of staffed beds in the U.S., through its affiliation with the VHA,...

Google Health: Open the Flood Gates

After 18 months in development, Google has unveiled its online personal health record (PHR) storage system, Google Health. Google brings its considerable know how and infrastructure to the space. The successful trial at the Cleveland Clinic validated the secure exchange of patient data between the Clinic and...

Upgraded Enlarged Prostate Treatment Catheter from Urologix: CTC Advance

This week, the OneMedPlace team is down in Orlando attending the American Urological Association’s annual meeting. We’ll be capturing some great video footage from the floor which we’ll be sharing later this month. While we’ve got Urology on the brain, I thought I’d weigh in on the recently...

Retractable Technologies Plods Along

Retractable Technologies, maker of safety needles, including the Vanish Point syringe, reported revenues of $5.3 million in its most recent quarter, down slightly from the $5.7 million reported in the same quarter last year. Overall, sales of syringes decreased about 20%, even as domestic unit sales...

Spectranetics Buys Kensey Nash Endovascular Unit

In a deal announced this week, Spectranetics will acquire Kensey Nash Corporation’s endovascular business for $10 million upfront and additional milestone payments of up to $14 million, pending sales, product development and FDA approval objectives. Spectranetics will get a suite of products that generated...

NxStage Shares Plummet on Q1 Financial Results

NxStage Medical, a Lawrence, MA, company that makes dialysis systems, saw its share price plummet after announcing its first quarter financial results. The company traded as high as $15 earlier this year, but closed under $5 on Tuesday. Though revenues grew nearly four-fold to $31.0 million (compared to $8.4...

Arbios Systems to Begin Pivotal Trials for its SEPET Liver Assist Device

Liver and biliary diseases affect 25 million Americans, whose annual healthcare costs exceed $10 billion. Unfortunately, there are no direct treatments available for liver failure and patients must receive a liver transplant or endure prolonged hospitalization with significant mortality. Arbios Systems is...